4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001807359-26-000018
Director sold 17,750 shares at an average $36.10 ($640,861)
- Director acquired 17,750 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Epperly Melissa B, · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +17,750 | $4.46 | $79,165 | 32,704 | D |
| 2026-10-01 | Sale : show line 2 in the form 10b5-1 | −16,850 | $36.08 | $607,948 | 15,854 | D |
| 2026-10-01 | Sale : show line 3 in the form 10b5-1 | −900 | $36.57 | $32,913 | 14,954 | D |
| Open-market sales · 17,750 sh · avg $36.10 · $640,861 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-01 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) | −17,750 | 151,416 | D |
Loading xslF345X06/wk-form4_1791237952.xml…